Aegle Therapeutics
- Website
- aegletherapeutics.com
- Total Funding
- $6.5M
- Last Round
- $6.5M Series ASep 2020
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Aegle Therapeutics is a Biotech company. It has raised $6.5M in total across 1 round, most recently a $6.5M Series A round in Sep 2020. Investors include Tellus BioVentures, DeepWork Capital and New World Angels.
Funding History
Sep 2020
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aegle-therapeutics"><img src="https://indexed.vc/api/badge/company/aegle-therapeutics" alt="Aegle Therapeutics on Indexed.vc" width="260" height="76" /></a>